These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38479857)

  • 21. Orodispersible films and tablets with prednisolone microparticles.
    Brniak W; Maślak E; Jachowicz R
    Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.
    Yehia SA; El-Ridi MS; Tadros MI; El-Sherif NG
    Pharm Dev Technol; 2015; 20(5):528-39. PubMed ID: 24490806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochloride.
    Hu X; Li Y; Zhang E; Wang X; Xing M; Wang Q; Lei J; Huang H
    AAPS PharmSciTech; 2013 Mar; 14(1):29-37. PubMed ID: 23180226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer.
    Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W
    Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.
    Haznar-Garbacz D; Hoc D; Garbacz G; Lachman M; Słomińska D; Romański M
    AAPS PharmSciTech; 2022 Jul; 23(6):203. PubMed ID: 35882674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
    Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
    J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Dissolution Model Can Predict the in Vivo Taste Masking Performance of Coated Multiparticulates.
    Keeley A; Teo M; Ali Z; Frost J; Ghimire M; Rajabi-Siahboomi A; Orlu M; Tuleu C
    Mol Pharm; 2019 May; 16(5):2095-2105. PubMed ID: 30900905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is rat a good model for assessment of particulate-based taste-masked formulations?
    Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
    Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method.
    Randale SA; Dabhi CS; Tekade AR; Belgamwar VS; Gattani SG; Surana SJ
    Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):443-8. PubMed ID: 20410620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
    Nakano Y; Maeda A; Uchida S; Namiki N
    Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
    Sheshala R; Khan N; Darwis Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
    Douroumis DD; Gryczke A; Schminke S
    AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet.
    Liew KB; Peh KK
    Arch Pharm Res; 2021 Aug; 44(8):1-10. PubMed ID: 25579848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.
    Ishikawa T; Watanabe Y; Utoguchi N; Matsumoto M
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1451-4. PubMed ID: 10553641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
    Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
    Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is bicarbonate buffer suitable as a dissolution medium?
    Boni JE; Brickl RS; Dressman J
    J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration.
    Lopalco A; Denora N; Laquintana V; Cutrignelli A; Franco M; Robota M; Hauschildt N; Mondelli F; Arduino I; Lopedota A
    Int J Pharm; 2020 Jan; 574():118922. PubMed ID: 31836482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.